202 related articles for article (PubMed ID: 14688282)
1. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions.
Ohnishi H; Miyata T; Yasuda H; Satoh Y; Hanatsuka K; Kita H; Ohashi A; Tamada K; Makita N; Iiri T; Ueda N; Mashima H; Sugano K
J Biol Chem; 2004 Mar; 279(10):8873-8. PubMed ID: 14688282
[TBL] [Abstract][Full Text] [Related]
2. Autocrine loop between TGF-beta1 and IL-1beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells.
Aoki H; Ohnishi H; Hama K; Ishijima T; Satoh Y; Hanatsuka K; Ohashi A; Wada S; Miyata T; Kita H; Yamamoto H; Osawa H; Sato K; Tamada K; Yasuda H; Mashima H; Sugano K
Am J Physiol Cell Physiol; 2006 Apr; 290(4):C1100-8. PubMed ID: 16371439
[TBL] [Abstract][Full Text] [Related]
3. Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells.
Aoki H; Ohnishi H; Hama K; Shinozaki S; Kita H; Yamamoto H; Osawa H; Sato K; Tamada K; Sugano K
J Cell Biochem; 2006 Sep; 99(1):221-8. PubMed ID: 16598747
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines.
Aoki H; Ohnishi H; Hama K; Shinozaki S; Kita H; Osawa H; Yamamoto H; Sato K; Tamada K; Sugano K
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C259-68. PubMed ID: 16837651
[TBL] [Abstract][Full Text] [Related]
5. Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1).
Xu XF; Liu F; Xin JQ; Fan JW; Wu N; Zhu LJ; Duan LF; Li YY; Zhang H
Biochem Biophys Res Commun; 2018 Jun; 501(2):365-373. PubMed ID: 29705706
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway.
Hama K; Ohnishi H; Aoki H; Kita H; Yamamoto H; Osawa H; Sato K; Tamada K; Mashima H; Yasuda H; Sugano K
Biochem Biophys Res Commun; 2006 Feb; 340(3):742-50. PubMed ID: 16380081
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
10. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
12. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.
Ungefroren H; Groth S; Sebens S; Lehnert H; Gieseler F; Fändrich F
Mol Cancer; 2011 May; 10():67. PubMed ID: 21624123
[TBL] [Abstract][Full Text] [Related]
16. Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways.
Leivonen SK; Chantry A; Hakkinen L; Han J; Kahari VM
J Biol Chem; 2002 Nov; 277(48):46338-46. PubMed ID: 12270924
[TBL] [Abstract][Full Text] [Related]
17. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
18. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
McKarns SC; Schwartz RH; Kaminski NE
J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
20. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts.
Furukawa F; Matsuzaki K; Mori S; Tahashi Y; Yoshida K; Sugano Y; Yamagata H; Matsushita M; Seki T; Inagaki Y; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2003 Oct; 38(4):879-89. PubMed ID: 14512875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]